Galmed Pharmaceuticals Ltd
Company Profile
Business description
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aramchol, is a disease-modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis. Aramchol affects liver fat metabolism and has been shown in a Phase IIa clinical study to reduce liver fat content, as well as improve metabolic parameters associated with Nonalcoholic steatohepatitis.
Contact
16 Tiomkin Street
Tel Aviv 6578317
ISRT: +972 36938448
E: info@galmedpharma.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2024
Employees
8
Stocks News & Analysis
stocks
An undervalued wide moat US share with momentum
stocks
3 shares with high dividend yields from our Global Best Ideas list
video
Our view of mining shares
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 8,198.70 | 9.90 | -0.12% |
| CAC 40 | 7,598.63 | 23.39 | -0.31% |
| DAX 40 | 18,557.70 | 150.63 | 0.82% |
| Dow JONES (US) | 40,358.09 | 57.35 | -0.14% |
| FTSE 100 | 8,167.37 | 31.41 | -0.38% |
| HKSE | 17,344.52 | 124.84 | -0.71% |
| NASDAQ | 17,997.35 | 10.22 | -0.06% |
| Nikkei 225 | 39,179.21 | 415.18 | -1.05% |
| NZX 50 Index | 12,530.99 | 105.41 | 0.85% |
| S&P 500 | 5,555.74 | 8.67 | -0.16% |
| S&P/ASX 200 | 7,956.80 | 14.30 | -0.18% |
| SSE Composite Index | 2,916.07 | 0.70 | 0.02% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Argosy Minerals Ltd AGY | 0.05 | 0.03 | -38.27% |
| Pilbara Minerals Ltd PLS | 2.91 | 0.02 | 0.52% |
| Droneshield Ltd DRO | 1.45 | 0.03 | 1.76% |
| Imugene Ltd IMU | 0.06 | 0.00 | -6.67% |
| Worley Ltd WOR | 15.20 | 0.01 | 0.03% |
| Mesoblast Ltd MSB | 1.25 | 0.06 | -4.41% |
| Core Lithium Ltd CXO | 0.10 | 0.00 | -3.06% |
| Sayona Mining Ltd SYA | 0.03 | 0.00 | -3.03% |
| Red 5 Ltd RED | 0.42 | 0.03 | 6.41% |
| Zip Co Ltd ZIP | 1.82 | 0.02 | 0.97% |